Anticancer activity of phyllanthus emblica Linn. (Indian Gooseberry): Inhibition of transcription factor ap-1 and HPV gene expression in cervical cancer cells

Nutrition and Cancer

Volumn 65, Issue SUPPL.1, 2013, Pages 88-97

  Mahata, Sutapa ^a   Pandey, Arvind ^a   Shukla, Shirish ^a,d   Tyagi, Abhishek ^a,b   Husain, Syed Akhtar ^c   Das, Bhudev Chandra ^b   Bharti, Alok Chandra ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b UNIVERSITY OF DELHI   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMBLICA OFFICINALIS EXTRACT; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND;

ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; CANCER CELL; CANCER INHIBITION; CELL DEATH; CONFERENCE PAPER; DNA BINDING; DOWN REGULATION; DRUG CARCINOGENICITY; DRUG EFFECT; DRUG MECHANISM; FRUIT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN VITRO STUDY; ONCOGENE C FOS; UTERINE CERVIX CANCER; VIRUS TRANSCRIPTION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; APOPTOSIS; CARCINOGENESIS; CELL SURVIVAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; FRUIT; HELA CELLS; HUMANS; PAPILLOMAVIRIDAE; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; PHYLLANTHUS EMBLICA;

EID: 84878543786     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.785008     Document Type: Conference Paper

References (58)

1. Krishnaveni, M, and, Mirunalini, S. 2010. Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol, 21: 93-105.
2. Asmawi, M Z, Kankaanranta, H, Moilanen, E, and, Vapaatalo, H. 1993. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol, 45: 581-584. (Pubitemid 23201446)
3. Thorat, S P, Rege, N N, Naik, A S, Thatte, U M, Joshi, A. 1995. Emblica officinalis: a novel therapy for acute pancreatitis-an experimental study. HPB Surg, 9: 25-30. (Pubitemid 26021907)
4. Bhattacharya, A, Kumar, M, Ghosal, S, and, Bhattacharya, S K. 2000. Effect of bioactive tannoid principles of Emblica officinalis on iron-induced hepatic toxicity in rats. Phytomedicine, 7: 173-175. (Pubitemid 30307618)
5. Dang, G K, Parekar, R R, Kamat, S K, Scindia, A M, and, Rege, N N. 2011. Antiinflammatory activity of Phyllanthus emblica, Plumbago zeylanica and Cyperus rotundus in acute models of inflammation. Phytother Res, 25: 904-908.
6. Muthuraman, A, Sood, S, and, Singla, S K. 2011. The antiinflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology, 19: 327-334.
7. Nicolis, E, Lampronti, I, Dechecchi, M C, Borgatti, M, Tamanini, A. 2008. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol, 8: 1672-1680.
8. Jose, J K, Kuttan, G, and, Kuttan, R. 2001. Antitumour activity of Emblica officinalis. J Ethnopharmacol, 75: 65-69. (Pubitemid 32303135)
9. Suresh, K, and, Vasudevan, D M. 1994. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol, 44: 55-60. (Pubitemid 24256659)
10. Zhang, Y J, Nagao, T, Tanaka, T, Yang, C R, Okabe, H. 2004. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol Pharm Bull, 27: 251-255. (Pubitemid 41694712)
11. Ihantola-Vormisto, A, Summanen, J, Kankaanranta, H, Vuorela, H, Asmawi, Z M. 1997. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med, 63: 518-524. (Pubitemid 28035446)
12. Perianayagam, J B, Sharma, S K, Joseph, A, and, Christina, A J. 2004. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol, 95: 83-85. (Pubitemid 39221415)
13. Nandi, P, Talukder, G, and, Sharma, A. 1997. Dietary chemoprevention of clastogenic effects of 3,4-benzo(a)pyrene by Emblica officinalis Gaertn. fruit extract. Br J Cancer, 76: 1279-1283. (Pubitemid 27474967)
14. Ahmad, I, Mehmood, Z, and, Mohammad, F. 1998. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol, 62: 183-193. (Pubitemid 28400990)
15. Hiraganahalli, B D, Chinampudur, V C, Dethe, S, Mundkinajeddu, D, Pandre, M K. 2012. Hepatoprotective and antioxidant activity of standardized herbal extracts. Pharmacogn Mag, 8: 116-123.
16. Jeena, K J, Joy, K L, and, Kuttan, R. 1999. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett, 136: 11-16. (Pubitemid 29142296)
17. Srirama, R, Deepak, H B, Senthilkumar, U, Ravikanth, G, Gurumurthy, B R. 2012. Hepatoprotective activity of Indian Phyllanthus. Pharm Biol
18. Shivananjappa, M M, and, Joshi, M K. 2012. Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2). Pharm Biol, 50: 497-505.
19. Bandyopadhyay, S K, Pakrash, S C, and, Pakrashi, A. 2000. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol, 70: 171-176. (Pubitemid 30193243)
20. Sairam, K, Rao Ch, V, Babu, M D, Kumar, K V, Agrawal, V K. 2002. Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study. J Ethnopharmacol, 82: 1-9.
21. Khan, M T, Lampronti, I, Martello, D, Bianchi, N, Jabbar, S. 2002. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Oncol, 21: 187-192.
22. Ngamkitidechakul, C, Jaijoy, K, Hansakul, P, Soonthornchareonnon, N, and, Sireeratawong, S. 2010. Antitumour effects of Phyllanthus emblica L.: induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother Res, 24: 1405-1413.
23. Jemal, A, Bray, F, Center, M M, Ferlay, J, Ward, E. 2011. Global cancer statistics. CA Cancer J Clin, 61: 69-90.
24. Bharti, A C, Shukla, S, Mahata, S, Hedau, S, and, Das, B C. 2010. Human papillomavirus and control of cervical cancer in India. Expert Rev Obstet Gynecol, 5: 329-346.
25. zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers: a brief historical account. Virology, 384: 260-265.
26. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2: 342-350. (Pubitemid 37328947)
27. Ho, G Y, Burk, R D, Klein, S, Kadish, A S, Chang, C J. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst, 87: 1365-1371.
28. Bodily, J, and, Laimins, L A. 2011. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol, 19: 33-39.
29. Bednarek, P H, Lee, B J, Gandhi, S, Lee, E, and, Phillips, B. 1998. Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting. J Virol, 72: 708-716. (Pubitemid 28048890)
30. Garcia-Carranca, A, Thierry, F, and, Yaniv, M. 1988. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J Virol, 62: 4321-4330.
31. Bernard, H U, and, Apt, D. 1994. Transcriptional control and cell type specificity of HPV gene expression. Arch Dermatol, 130: 210-215. (Pubitemid 24056048)
32. Prusty, B K, and, Das, B C. 2005. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer, 113: 951-960. (Pubitemid 40096875)
33. Mahata, S, Bharti, A C, Shukla, S, Tyagi, A, Husain, S A. 2011. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer, 10: 39
34. Mahata, S, Maru, S, Shukla, S, Pandey, A, Mugesh, G. 2012. Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells. BMC Complement Altern Med, 12: 15
35. Dignam, J D, Lebovitz, R M, and, Roeder, R G. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res, 11: 1475-1489.
36. Mishra, A, Bharti, A C, Saluja, D, and, Das, B C. 2010. Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer. Int J Cancer, 126: 819-829.
37. Bharti, A C, Donato, N, Singh, S, and, Aggarwal, B B. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101: 1053-1062. (Pubitemid 36139379)
38. Penolazzi, L, Lampronti, I, Borgatti, M, Khan, M T, Zennaro, M. 2008. Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis. BMC Complement Altern Med, 8: 59
39. Fujii, T, Wakaizumi, M, Ikami, T, and, Saito, M. 2008. Amla (Emblica officinalis Gaertn.) extract promotes procollagen production and inhibits matrix metalloproteinase-1 in human skin fibroblasts. J Ethnopharmacol, 119: 53-57.
40. Yokozawa, T., Kim, H. Y., Kim, H. J., Okubo, T., Chu, D. C. 2007. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr, 97: 1187-1195. (Pubitemid 46925372)
41. Yokozawa, T, Kim, H Y, Kim, H J, Tanaka, T, Sugino, H. 2007. Amla (Emblica officinalis Gaertn.) attenuates age-related renal dysfunction by oxidative stress. J Agric Food Chem, 55: 7744-7752. (Pubitemid 47522183)
42. Reddy, V G, Khanna, N, and, Singh, N. 2001. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem Biophys Res Commun, 282: 409-415. (Pubitemid 32917884)
43. Ott, M, Thyagarajan, S P, and, Gupta, S. 1997. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. Eur J Clin Invest, 27: 908-915. (Pubitemid 27483524)
44. Kiemer, A K, Hartung, T, Huber, C, and, Vollmar, A M. 2003. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J Hepatol, 38: 289-297. (Pubitemid 36286541)
45. Zhang, Y J, Abe, T, Tanaka, T, Yang, C R, and, Kouno, I. 2001. Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J Nat Prod, 64: 1527-1532. (Pubitemid 34051972)
46. Butz, K, and, Hoppe-Seyler, F. 1993. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol, 67: 6476-6486. (Pubitemid 23309113)
47. Rosl, F, Das, B C, Lengert, M, Geletneky, K, and, zur Hausen, H. 1997. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol, 71: 362-370. (Pubitemid 26412300)
48. Shaulian, E, and, Karin, M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol, 4: E131-E136.
49. Shaulian, E, and, Karin, M. 2001. AP-1 in cell proliferation and survival. Oncogene, 20: 2390-2400. (Pubitemid 32531297)
50. Ameyar, M, Wisniewska, M, and, Weitzman, J B. 2003. A role for AP-1 in apoptosis: the case for and against. Biochimie, 85: 747-752. (Pubitemid 37383793)
51. Jin, Y J, Lee, J H, Kim, Y M, Oh, G T, and, Lee, H. 2012. Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. Cell Signal, 24: 1485-1495.
52. Singh, N K, Quyen, D V, Kundumani-Sridharan, V, Brooks, P C, and, Rao, G N. 2010. AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis. J Biol Chem, 285: 16830-16843.
53. el-Mekkawy, S, Meselhy, M R, Kusumoto, I T, Kadota, S, Hattori, M. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo), 43: 641-648.
54. Liu, Q, Wang, Y F, Chen, R J, Zhang, M Y, Yang, C R. 2009. Anti-coxsackie virus B3 norsesquiterpenoids from the roots of Phyllanthus emblica. J Nat Prod, 72: 969-972.
55. Xiang, Y F, Ju, H Q, Li, S, Zhang, Y J, Yang, C R. 2010. Effects of 1,2,4,6-tetra-O-galloyl-beta-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture. Virol Sin, 25: 375-380.
56. Xiang, Y, Pei, Y, Qu, C, Lai, Z, Ren, Z. 2011. In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-beta-d-glucose from Phyllanthus emblica L. (Euphorbiaceae). Phytother Res, 25: 975-982.
57. Talwar, G P, Dar, S A, Rai, M K, Reddy, K V, and, Mitra, D. 2008. A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int J Antimicrob Agents, 32: 180-185.
58. Rajeshkumar, N V, Pillai, M R, and, Kuttan, R. 2003. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. J Exp Clin Cancer Res, 22: 201-212. (Pubitemid 36734178)